|
觀察阿托伐他汀、氯吡格雷聯(lián)合治療冠心病心絞痛的臨床效果
泰州市人民醫(yī)院 朱曉紅 2020/2/5 16:21:40
To observe the clinical effect of Atorvastatin Combined with clopidogrel in the treatment of angina pectoris of coronary heart disease
摘要：目的：分析阿托伐他汀、氯吡格雷聯(lián)合治療冠心病心絞痛的臨床效果。方法：選取我院2017年5月到2018年6月98例患者，將本次選取的患者進(jìn)行分組對(duì)比，分組方式采用的是隨機(jī)數(shù)字表法，本次分為對(duì)照組和試驗(yàn)組，每組各49例患者，對(duì)照組采用阿托伐汀，試驗(yàn)組給予阿托伐汀聯(lián)合氯吡格雷，對(duì)比兩組患者的血液流變情況和心功能指標(biāo)改善情況。結(jié)果：試驗(yàn)組的血液流變情況、心功能改善情況明顯優(yōu)于對(duì)照組，兩組數(shù)據(jù)對(duì)比，經(jīng)過統(tǒng)計(jì)學(xué)計(jì)算顯示有差異存在，說明對(duì)比有統(tǒng)計(jì)學(xué)意義P均﹤0.05，試驗(yàn)組的不良反應(yīng)明顯低于對(duì)照組，具有統(tǒng)計(jì)學(xué)意義p﹤0.05。結(jié)論：使用阿托伐汀聯(lián)合氯吡格雷治療冠心病心絞痛有明顯的是治療效果，改善了患者的心功能指標(biāo)，值得臨床推廣應(yīng)用。
ABSTRACT: Objective: To analyze the clinical effect of Atorvastatin Combined with clopidogrel in the treatment of coronary heart disease angina pectoris. Methods: 98 patients were selected from May 2017 to June 2018 in our hospital. The patients were divided into two groups: control group and experimental group. 49 patients in each group were divided into control group and experimental group. The control group was treated with atorvastatin and clopidogrel. The blood rheology and cardiac function of the two groups were compared. Good situation. Result: The improvement of blood rheology and cardiac function in the experimental group was significantly better than that in the control group. The data comparison between the two groups showed that there were differences. It showed that the comparison had statistical significance P ﹤ 0.05, and the adverse reactions in the experimental group were significantly lower than those in the control group, with statistical significance P ﹤ 0.05. CONCLUSION: Atorvastin combined with clopidogrel in the treatment of angina pectoris of coronary heart disease has obvious therapeutic effect and improves the cardiac function of patients, which is worthy of clinical application.
關(guān)鍵詞：阿托伐�。宦冗粮窭�；冠心病心絞痛
Key words: atorvastatin; clopidogrel; coronary heart disease angina pectoris
臨床心血管疾病中，冠心病屬于最常見的一種疾病類型。相關(guān)研究指出，脂類物質(zhì)異常代謝是導(dǎo)致冠心病形成的主要原因，繼而導(dǎo)致大量堆積，最終導(dǎo)致了動(dòng)脈阻塞的發(fā)生，不僅發(fā)病率較高，而且具有較高的死亡率，對(duì)患者的日常生活和身體健康產(chǎn)生了嚴(yán)重影響。在冠心病發(fā)生后，患者的臨床癥狀可分為多種，其中的的心絞痛屬于最常見的臨床表。不穩(wěn)定型心絞痛是比較常見的一種心絞痛類型，屬于一種（未完，下一頁(yè)）
|